| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,926 | 3,899 | 2,972 | | Cost of Revenue | 1,196 | 1,240 | 871 | | | Gross Profit | 3,730 | 2,659 | 2,101 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 877 | 822 | 829 | | Non Recurring |
-
|
-
|
-
| | Others | 1,075 | 806 | 677 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,779 | 1,031 | 595 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 5 | 5 | | Earnings Before Interest And Taxes | 1,781 | 1,037 | 600 | | Interest Expense | 82 | 105 | 24 | | Income Before Tax | 1,699 | 931 | 576 | | Income Tax Expense | 528 | 218 | (28) | | Minority Interest |
-
|
-
| 5 | | | | Net Income From Continuing Ops | 1,171 | 714 | 608 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,171 | 714 | 608 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,171 | $714 | $608 |
|
0.26% Nasdaq 
Income Statement
